ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading  ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading
Related Posts

Gold Cools From Highs as Fed Rate-Hike Odds Jump to 66%
- Raj Gaurav Rai
- September 12, 2026
Gold eases from recent highs as Fed rate-hike odds jump to 66% from under 40% a week ago — even as crude oil and geopolitical tensions stay elevated.
stocks to buy BUY BOROSIL RENEWABLES 518 STOPLOSS 490 TARGET 590 – 600 .#StockMarket #FinancialNews #Trading stocks to buy BUY BOROSIL RENEWABLES 518 STOPLOSS 490 TARGET 590 – 600 .#StockMarket #FinancialNews #Trading
- Raj Gaurav Rai
- July 24, 2024
stocks to buy BUY BOROSIL RENEWABLES 518 STOPLOSS 490 TARGET 590 – 600 .#StockMarket #FinancialNews #Trading stocks to buy BUY BOROSIL RENEWABLES 518 STOPLOSS 490 […]
BREAKING Nirmala Sitharaman to present Budget on July 23. StockMarket #FinancialNews #Investment BREAKING Nirmala Sitharaman to present Budget on July 23 StockMarket #FinancialNews #Investment
- Raj Gaurav Rai
- July 6, 2024
BREAKING Nirmala Sitharaman to present Budget on July 23. StockMarket #FinancialNews #Investment BREAKING Nirmala Sitharaman to present Budget on July 23 StockMarket #FinancialNews #Investment Please […]